Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2019-05-01
|
| Serija: | Blood Pressure |
| Online dostop: | http://dx.doi.org/10.1080/08037051.2019.1614278 |
| Oznake: |
Brez oznak, prvi označite!
|
